Found: 18
Select item for more details and to access through your institution.
Risk of renal events during tenofovir disoproxil fumarate and entecavir antiviral prophylaxis in HBsAg‐positive cancer patients undergoing chemotherapy.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1599, doi. 10.1111/jvh.12984
- By:
- Publication type:
- Article
Predictors of Response and Survival in Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 182, doi. 10.3390/cancers12010182
- By:
- Publication type:
- Article
Cationic liposome coupled endostatin gene for treatment of peritoneal colon cancer.
- Published in:
- Clinical & Experimental Metastasis, 2010, v. 27, n. 5, p. 307, doi. 10.1007/s10585-010-9328-x
- By:
- Publication type:
- Article
HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
- Published in:
- Oncogene, 2002, v. 21, n. 31, p. 4801, doi. 10.1038/sj.onc.1205589
- By:
- Publication type:
- Article
Inhibitory Effects of Amentoflavone and Orobol on Daclatasvir-Induced Resistance-Associated Variants of Hepatitis C Virus.
- Published in:
- American Journal of Chinese Medicine, 2018, v. 46, n. 4, p. 835, doi. 10.1142/S0192415X18500441
- By:
- Publication type:
- Article
Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease.
- Published in:
- Gastroenterology Research & Practice, 2017, p. 1, doi. 10.1155/2017/9279836
- By:
- Publication type:
- Article
Ser38‐His93‐Asn91 triad confers resistance of JFH1 HCV NS5A‐Y93H variant to NS5A inhibitors.
- Published in:
- FEBS Journal, 2024, v. 291, n. 6, p. 1264, doi. 10.1111/febs.17039
- By:
- Publication type:
- Article
Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 5, p. 1, doi. 10.1371/journal.ppat.1004163
- By:
- Publication type:
- Article
Durable objective response to sorafenib and role of sequential treatment in unresectable hepatocellular carcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221099401
- By:
- Publication type:
- Article
Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13657-5
- By:
- Publication type:
- Article
Incidence and Predictors of HBsAg Loss After Peginterferon Therapy in HBeAg-Negative Chronic Hepatitis B: A Multicenter, Long-term Follow-up Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inverse Association between Hepatitis B Virus Infection and Fatty Liver Disease: A Large-Scale Study in Populations Seeking for Check-Up.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072049
- By:
- Publication type:
- Article
In vivo Adenovirus-mediated Prodrug Gene Therapy for Carcinoembryonic Antigen-producing Pancreatic Cancer.
- Published in:
- Cancer Science, 1998, v. 89, n. 4, p. 457, doi. 10.1111/j.1349-7006.1998.tb00585.x
- By:
- Publication type:
- Article
Seroprevalence of GB virus C/hepatitis G virus–RNA and anti-envelope antibody in high-risk populations in Taiwan.
- Published in:
- Journal of Gastroenterology & Hepatology, 2000, v. 15, n. 10, p. 1171
- By:
- Publication type:
- Article
Multiple effects of honokiol on the life cycle of hepatitis C virus.
- Published in:
- Liver International, 2012, v. 32, n. 6, p. 989, doi. 10.1111/j.1478-3231.2011.02621.x
- By:
- Publication type:
- Article
Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 11, p. 2568, doi. 10.1093/carcin/bgt243
- By:
- Publication type:
- Article
Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 11335, doi. 10.3390/ijms231911335
- By:
- Publication type:
- Article